» Articles » PMID: 33496225

Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020

Overview
Date 2021 Jan 26
PMID 33496225
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

To improve recognition of coronavirus disease (COVID-19) and inform clinical and public health guidance, we randomly selected 600 COVID-19 case-patients in Colorado. A telephone questionnaire captured symptoms experienced, when symptoms occurred, and how long each lasted. Among 128 hospitalized patients, commonly reported symptoms included fever (84%), fatigue (83%), cough (73%), and dyspnea (72%). Among 236 nonhospitalized patients, commonly reported symptoms included fatigue (90%), fever (83%), cough (83%), and myalgia (74%). The most commonly reported initial symptoms were cough (21%-25%) and fever (20%-25%). In multivariable analysis, vomiting, dyspnea, altered mental status, dehydration, and wheezing were significantly associated with hospitalization, whereas rhinorrhea, headache, sore throat, and anosmia or ageusia were significantly associated with nonhospitalization. General symptoms and upper respiratory symptoms occurred earlier in disease, and anosmia, ageusia, lower respiratory symptoms, and gastrointestinal symptoms occurred later. Symptoms should be considered alongside other epidemiologic factors in clinical and public health decisions regarding potential COVID-19 cases.

Citing Articles

Spectrum of COVID-19 cases in Arkhangelsk, Northwest Russia: Findings from a population-based study linking serosurvey, registry data, and self-reports of symptoms.

Krieger E, Kudryavtsev A, Sharashova E, Samodova O, Kontsevaya A, Postoev V PLoS One. 2024; 19(10):e0311287.

PMID: 39392813 PMC: 11469529. DOI: 10.1371/journal.pone.0311287.


Pulmonary function trajectories in COVID-19 survivors with and without pre-existing respiratory disease.

Gach D, Beijers R, van Zeeland R, van Kampen-van den Boogaart V, Posthuma R, Schols A Sci Rep. 2024; 14(1):16571.

PMID: 39019957 PMC: 11255309. DOI: 10.1038/s41598-024-67314-0.


Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design.

Malambo W, Chanda D, Besa L, Engamba D, Mwiinga L, Mwitumwa M PLoS One. 2024; 19(7):e0306131.

PMID: 38954717 PMC: 11219000. DOI: 10.1371/journal.pone.0306131.


Investigating the effects of the Omicron variant of COVID-19 on sperm parameters and serum levels of male sexual hormones: Prospective observational study.

Mohammadi Y, Ranjbaran J, Mamashli M, Marzuni H, Dashtgard A, Mohsenizadeh S New Microbes New Infect. 2024; 60-61:101432.

PMID: 38800713 PMC: 11126988. DOI: 10.1016/j.nmni.2024.101432.


Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.

Mitsikostas D, Caronna E, de Tommaso M, Deligianni C, Ekizoglu E, Bolay H Eur J Neurol. 2024; 31(6):e16251.

PMID: 38415282 PMC: 11235838. DOI: 10.1111/ene.16251.


References
1.
Holshue M, DeBolt C, Lindquist S, Lofy K, Wiesman J, Bruce H . First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929-936. PMC: 7092802. DOI: 10.1056/NEJMoa2001191. View

2.
Paderno A, Mattavelli D, Rampinelli V, Grammatica A, Raffetti E, Tomasoni M . Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects. Otolaryngol Head Neck Surg. 2020; 163(6):1144-1149. PMC: 7331108. DOI: 10.1177/0194599820939538. View

3.
. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

4.
Van den Bergh O, Walentynowicz M . Accuracy and bias in retrospective symptom reporting. Curr Opin Psychiatry. 2016; 29(5):302-8. DOI: 10.1097/YCO.0000000000000267. View

5.
Nobel Y, Phipps M, Zucker J, Lebwohl B, Wang T, Sobieszczyk M . Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States. Gastroenterology. 2020; 159(1):373-375.e2. PMC: 7152871. DOI: 10.1053/j.gastro.2020.04.017. View